Price
Target price
€3.06
€3.06
6.080%
0.175
6.080%
€27.00
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Relief Therapeutics Holding
sharewise wants to provide you with the best news and tools for Relief Therapeutics Holding, so we directly link to the best financial data sources.
Financials
News
Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook Ahead of Anticipated Business Combination
Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook Ahead of Anticipated Business Combination
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
Relief Therapeutics Convenes Extraordinary General Meeting
Relief Therapeutics Convenes Extraordinary General Meeting
Relief Therapeutics and NeuroX, Successor to MindMaze, Sign Definitive Agreement for Business Combination
Relief Therapeutics and NeuroX, Successor to MindMaze, Sign Definitive Agreement for Business Combination
Relief Therapeutics Publishes 2025 Half-Year Report
Relief Therapeutics Publishes 2025 Half-Year Report
Relief Therapeutics Advances Publication of 2025 Half-Year Report
Relief Therapeutics Advances Publication of 2025 Half-Year Report
Relief Therapeutics Announces Proposed Business Combination with NeuroX, successor to MindMaze
Relief Therapeutics Announces Proposed Business Combination with NeuroX, successor to MindMaze
Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011
Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011
Relief Therapeutics Announces Results of Annual General Meeting
Relief Therapeutics Announces Results of Annual General Meeting